Mobile Health, Big Data, Antimicrobial Resistance Central to 2014 Meeting
|
By LabMedica International staff writers Posted on 29 Jul 2014 |
|
The 2014 American Association of Clinical Chemistry (AACC; Washington DC, USA) annual meeting & clinical lab expo, which is taking place in Chicago (IL, USA) from July 27-31, 2014, focuses on mobile health, big data, and antimicrobial resistance, among many other major healthcare topics.
The meeting and clinical expo is expected to draw more than 17,500 attendees, including prominent leaders in medicine and healthcare, to Chicago’s McCormick Place. Six hundred fifty exhibitors will also introduce more than 200 new diagnostic products, making this one of the 10 largest medical exhibitions in the US.
Mobile health: digital health guru Eric Topol, MD, will deliver the keynote lecture on how mobile technology and the internet are transforming healthcare. A symposium will cover how lab-on-a-chip technology can combat illegal designer drugs, and will look at two experimental technologies that could be the future of illicit drug testing: a point-of-care volumetric bar-chart chip and a miniaturized mass spectrometry device.
Big data: Monday’s plenary speaker Viktor Mayer-Schönberger, coauthor of Big Data: A Revolution That Will Transform How We Live, Work, and Think, will explore how the medical world can harness the massive amounts of data generated by genomic, proteomic, and metabolomic analyses to create new diagnostic tests and disease treatments.
Infectious diseases: The World Health Organization (WHO; Geneva, Switzerland) found that microbial drug resistance has become a serious public health threat worldwide. This is a troubling trend that the short course “Hot Topics in Clinical Microbiology” will examine. Two other sessions will also focus on MALDI-TOF MS, a rising diagnostic technology that is poised to replace standard infectious disease testing techniques—some of which date back to the 1800s—and that could become an important weapon in the fight against antimicrobial resistance.
Diagnostic innovations: from smart phone-based diagnostic readers, to biochips with the potential to diagnose human immunodeficiency virus (HIV), to the first human papilloma virus (HPV) test approved for primary cervical cancer screening. The latest diagnostic technology in mobile health, infectious diseases, reproductive health, and more will also be displayed at the AACC Clinical Lab Expo.
At the 2014 AACC Annual Meeting & Clinical Lab Expo plenary sessions feature expert presentations on how mobile technology and the internet are revolutionizing healthcare, the importance of newborn screening, big data, the biologic basis of obesity, and the latest advances that could lead to a cure for HIV. Six hundred and fifty exhibitors will be demonstrating displays of the latest diagnostic their technologies, including but not limited to automation, information systems, point-of-care (POC), and biotech.
Related Links:
World Health Organization
American Association of Clinical Chemistry
The meeting and clinical expo is expected to draw more than 17,500 attendees, including prominent leaders in medicine and healthcare, to Chicago’s McCormick Place. Six hundred fifty exhibitors will also introduce more than 200 new diagnostic products, making this one of the 10 largest medical exhibitions in the US.
Mobile health: digital health guru Eric Topol, MD, will deliver the keynote lecture on how mobile technology and the internet are transforming healthcare. A symposium will cover how lab-on-a-chip technology can combat illegal designer drugs, and will look at two experimental technologies that could be the future of illicit drug testing: a point-of-care volumetric bar-chart chip and a miniaturized mass spectrometry device.
Big data: Monday’s plenary speaker Viktor Mayer-Schönberger, coauthor of Big Data: A Revolution That Will Transform How We Live, Work, and Think, will explore how the medical world can harness the massive amounts of data generated by genomic, proteomic, and metabolomic analyses to create new diagnostic tests and disease treatments.
Infectious diseases: The World Health Organization (WHO; Geneva, Switzerland) found that microbial drug resistance has become a serious public health threat worldwide. This is a troubling trend that the short course “Hot Topics in Clinical Microbiology” will examine. Two other sessions will also focus on MALDI-TOF MS, a rising diagnostic technology that is poised to replace standard infectious disease testing techniques—some of which date back to the 1800s—and that could become an important weapon in the fight against antimicrobial resistance.
Diagnostic innovations: from smart phone-based diagnostic readers, to biochips with the potential to diagnose human immunodeficiency virus (HIV), to the first human papilloma virus (HPV) test approved for primary cervical cancer screening. The latest diagnostic technology in mobile health, infectious diseases, reproductive health, and more will also be displayed at the AACC Clinical Lab Expo.
At the 2014 AACC Annual Meeting & Clinical Lab Expo plenary sessions feature expert presentations on how mobile technology and the internet are revolutionizing healthcare, the importance of newborn screening, big data, the biologic basis of obesity, and the latest advances that could lead to a cure for HIV. Six hundred and fifty exhibitors will be demonstrating displays of the latest diagnostic their technologies, including but not limited to automation, information systems, point-of-care (POC), and biotech.
Related Links:
World Health Organization
American Association of Clinical Chemistry
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Real-time PCR System
GentierX3 Series
Latest AACC 2014 News
- Corgenix Diagnostic Ebola Test Research Earns Abstract Award
- Atomo's Blood Test Unveiled at 2014 AACC; Takes Top Award in NY
- Roche Partners with Customers, Redefines Laboratory Value
- Abbott Showcases Innovations, Helps Labs Solve Health Care Challenges
- Sony DADC BioSciences and TSMC Receive AACC Award
- Oncolab Exhibits Pioneering AMAS Cancer Test at AACC
- Thermo Fisher Scientific Showcases Expanded Offering for Clinical Laboratory
- Major Advances in Medical Studies Highlighted at AACC 2014
- Wheaton Offers Unique Solutions for the Clinical Market
- Seegene Reveals New Real-Time PCR at AACC 2014
- AACC Debuts Refreshed Brand Identity
- EKF Highlights Growing Product Portfolio at AACC 2014 Meeting
Channels
Clinical Chemistry
view channel
3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models
Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more.jpg "Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)")
POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection
Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more
Highly Reliable Cell-Based Assay Enables Accurate Diagnosis of Endocrine Diseases
The conventional methods for measuring free cortisol, the body's stress hormone, from blood or saliva are quite demanding and require sample processing. The most common method, therefore, involves collecting... Read more
Molecular Diagnostics
view channel
Blood Proteins Could Warn of Cancer Seven Years before Diagnosis
Two studies have identified proteins in the blood that could potentially alert individuals to the presence of cancer more than seven years before the disease is clinically diagnosed. Researchers found... Read more (1)_1.jpg "Image: Ultrasound image of micro-histotripsy liberation of biomarkers in a tumor (Photo courtesy of Joy Wang and Pradyumna Kedarisetti)"){kind=small}
Ultrasound-Aided Blood Testing Detects Cancer Biomarkers from Cells
Ultrasound imaging serves as a noninvasive method to locate and monitor cancerous tumors effectively. However, crucial details about the cancer, such as the specific types of cells and genetic mutations... Read more_1.jpg "Image: The innovative method to customize and strengthen DNA origami structure promises breakthroughs in medicine (Photo courtesy of Shutterstock)")
.jpg "Image: The QIAstat-Dx Respiratory Panel Plus has received U.S. FDA clearance (Photo courtesy of QIAGEN)")
Hematology
view channel
Next Generation Instrument Screens for Hemoglobin Disorders in Newborns
Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more
First 4-in-1 Nucleic Acid Test for Arbovirus Screening to Reduce Risk of Transfusion-Transmitted Infections
Arboviruses represent an emerging global health threat, exacerbated by climate change and increased international travel that is facilitating their spread across new regions. Chikungunya, dengue, West... Read more
POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy
Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more
First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy
Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read moreImmunology
view channel.jpg "Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)")
AI Predicts Tumor-Killing Cells with High Accuracy
Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more
Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies
Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more
AI Tool Precisely Matches Cancer Drugs to Patients Using Information from Each Tumor Cell
Current strategies for matching cancer patients with specific treatments often depend on bulk sequencing of tumor DNA and RNA, which provides an average profile from all cells within a tumor sample.... Read more
Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment
Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read moreMicrobiology
view channel
Integrated Solution Ushers New Era of Automated Tuberculosis Testing
Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more
Automated Sepsis Test System Enables Rapid Diagnosis for Patients with Severe Bloodstream Infections
Sepsis affects up to 50 million people globally each year, with bacteraemia, formerly known as blood poisoning, being a major cause. In the United States alone, approximately two million individuals are... Read more
Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases
GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more
Clinical Decision Support Software a Game-Changer in Antimicrobial Resistance Battle
Antimicrobial resistance (AMR) is a serious global public health concern that claims millions of lives every year. It primarily results from the inappropriate and excessive use of antibiotics, which reduces... Read morePathology
view channel
AI Integrated With Optical Imaging Technology Enables Rapid Intraoperative Diagnosis
Rapid and accurate intraoperative diagnosis is essential for tumor surgery as it guides surgical decisions with precision. Traditional intraoperative assessments, such as frozen sections based on H&E... Read more
HPV Self-Collection Solution Improves Access to Cervical Cancer Testing
Annually, over 604,000 women across the world are diagnosed with cervical cancer, and about 342,000 die from this disease, which is preventable and primarily caused by the Human Papillomavirus (HPV).... Read more
Hyperspectral Dark-Field Microscopy Enables Rapid and Accurate Identification of Cancerous Tissues
Breast cancer remains a major cause of cancer-related mortality among women. Breast-conserving surgery (BCS), also known as lumpectomy, is the removal of the cancerous lump and a small margin of surrounding tissue.... Read more
Technology
view channel
New Diagnostic System Achieves PCR Testing Accuracy
While PCR tests are the gold standard of accuracy for virology testing, they come with limitations such as complexity, the need for skilled lab operators, and longer result times. They also require complex... Read more
DNA Biosensor Enables Early Diagnosis of Cervical Cancer
Molybdenum disulfide (MoS2), recognized for its potential to form two-dimensional nanosheets like graphene, is a material that's increasingly catching the eye of the scientific community.... Read more
Self-Heating Microfluidic Devices Can Detect Diseases in Tiny Blood or Fluid Samples
Microfluidics, which are miniature devices that control the flow of liquids and facilitate chemical reactions, play a key role in disease detection from small samples of blood or other fluids.... Read more
Breakthrough in Diagnostic Technology Could Make On-The-Spot Testing Widely Accessible
Home testing gained significant importance during the COVID-19 pandemic, yet the availability of rapid tests is limited, and most of them can only drive one liquid across the strip, leading to continued... Read moreIndustry
view channel
Danaher and Johns Hopkins University Collaborate to Improve Neurological Diagnosis
Unlike severe traumatic brain injury (TBI), mild TBI often does not show clear correlations with abnormalities detected through head computed tomography (CT) scans. Consequently, there is a pressing need... Read more
Beckman Coulter and MeMed Expand Host Immune Response Diagnostics Partnership
Beckman Coulter Diagnostics (Brea, CA, USA) and MeMed BV (Haifa, Israel) have expanded their host immune response diagnostics partnership. Beckman Coulter is now an authorized distributor of the MeMed... Read more_1.jpg "Image: Thermo Fisher will distribute Bio-Techne products across Europe (Photo courtesy of 123RF)")
